Last reviewed · How we verify
NCT05987462
The Effect of Green Walking on Myocardial Infarction Patients
NA trial testing Green walking in Myocardial Infarction in 60 participants. Completed in 30 June 2022.
15 April 2022
Quick facts
| Lead sponsor | AYNUR CİN |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 1 February 2022 |
| Primary completion | 15 April 2022 |
| Estimated completion | 30 June 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Green walking
Conditions studied
- Myocardial Infarction — all drugs for Myocardial Infarction →
- Quality of Life — all drugs for Quality of Life →
Sponsor
AYNUR CİN
Who can join
Adults 18 to 85, any sex, with Myocardial Infarction or Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this quasi-experimental study, which involved having patients who had experienced a MI engage in 50 minute green walks three times a week for 12 weeks, the following hypotheses were tested: High-intensity interval green walking has the effect of reducing the anthropometric measurements of patients undergoing MI. High-intensity interval green walking has the effect of reducing LDL, triglyceride, total cholesterol levels and increasing HDL levels of patients who have with MI. High-intensity interval green walking has a positive effect on the perception of disease of patients who have undergone MI. High-intensity interval green walking has an effect on improving the quality of life of patients with MI. Research Question 1: What is the impact of green walking on the body mass index (BMI) of patients with MI? Research Question 2: How does green walking influence blood lipid levels (triglycerides, LDL, total cholesterol, and HDL) in patients with MI? Research Question 3: What is the effect of green walking on the perception of the disease in patients with MI? Research Question 4: How does green walking affect the quality of life of patients with MI? 2 Groups: Green walking group and control group
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05987462
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Myocardial Infarction
Currently open trials in the same condition.
- NCT07257198 — Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone · Phase 3 · recruiting
- NCT07402642 — Effect of Early Educational Intervention on Cardiovascular Risk Factors After Acute Coronary Syndrome · NA · recruiting
- NCT07301034 — A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, · Phase 3 · recruiting
- NCT07142265 — Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients · recruiting
- NCT07138911 — Effect of Home-based Exercise Plan Mediated by Use of Digital Health App on Kinesiophobia and Functional Capacity · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05987462 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by AYNUR CİN
- Last refreshed: 17 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05987462.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing